Alopecia Pipeline
An overview of treatments for pattern baldness and alopecia which will be in the clinical trial stage during 2023. Androgenetic Alopecia Trials Chong Kun Dang Pharmaceutical – We begin the list with a newcomer, previously unannounced. CKD-843 is a new injectable drug being trialed in “alopecia” by the Chong Kun Dang (CKD) Pharmaceutical company of Seoul,…
Read MoreThis article contains a complete list and description of every known biotech and med-tech company working on a clinical therapy for hair loss prevention/hair growth from all phases spanning research to late-stage clinical trials in 2023. Over the past several years, the amount of new hair growth related technologies in development have multiplied like never…
Read More
Brickell Biotech, a dermatology-focused pharmaceutical company, is developing a therapy which should prove to be of interest to the online hair community. The company is based in Boulder, CO and has a variety of clinical programs underway in the area of dermatology. One such program is an oral CRTH2 antagonist for hair loss. A “CRTH2…
Read More
This article is a news feed containing brief updates of the most important hair growth treatment and hair loss cure news. It’s updated several times a week.
Read More
Updated October 2023 This post contains a list of the most viable and relevant hair regeneration treatments which are in development. They can be referred to as hair loss cures, baldness cures, hair growth treatments, hair loss treatments, or cures for androgenic alopecia. The treatments listed in this guide are ranked by a combination of…
Read More